Biotech Soars On New Agreements

Biotech Soars On New Agreements

Biotech Soars On New Agreements By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, October 4, 2023

A Colorado-based healthcare company is finding tremendous success so far on Tuesday after the company announced strategic agreements to expand its current product line and create new revenue opportunities. 

Shares of Vivos Therapeutics Inc. (Nasdaq:VVOS) soared on the news, topping out at $0.4498/share (+143.14%) at the session high. This move came on massive relative volume, so it could be an indication of things to come!

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Canadian Manufacturing and Wholesale Sales Point to Weakening Economy and Raise Possibilities of Rate Cuts
Drill Less, Extract More: This Just Announced Merger Unlocks Profits
100,000,000 Euro Commitment Sends Shares of this MicroCap Hydrogen Automaker Soaring
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top